DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

Vaccine

Volumn 14, Issue 13, 1996, Pages 1230-1234

  Bourne, Nigel ^a   Milligan, Gregg N ^a   Schleiss, Mark R ^a   Bernstein, David I ^a   Stanberry, Lawrence R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

DNA vaccine; Genital herpes; Herpes simplex virus

Indexed keywords

DNA VACCINE; HERPES SIMPLEX VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; VACCINES, DNA; VAGINA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0030250533     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00027-8     Document Type: Article

References (35)

1. 1 Wolff, J.A., Malone, R.W., Williams, P. et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247, 1465-1468
2. 2 Tang, D.-C., DeVit, M. and Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154
3. 3 Vahlsing, H.L., Yankauckas, M.A., Sawdey, M., Gromkowski, S.H. and Manthrope, M. Immunization with plasmid DNA using a pneumatic gun. J. Immun. Meth. 1994, 175, 11-17
4. 4 Robinson, H.L., Hunt, L.A. and Webster, R.G. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 1993, 11, 957-960
5. 5 Fynan, E.F., Webster, R.G., Fuller, D.H., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 1993, 90, 11478-11482
6. 6 Raz, E., Carson, D.A., Parker, S.E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 1994, 91, 9519-9523
7. 7 Ulmer, J.B., Donnelly, J.J., Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749
8. 8 Webster, R.G., Fynan, E.F., Santoro, J.C. and Robinson, H. Protection of ferrets against influenza challenge with a DNA vaccine to the hemagglutinin. Vaccine 1994, 12, 1495-1498
9. 9 Donnelly, J.J., Friedman, A., Martinez, D. et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Med. 1995, 1, 583-587
10. 10 Xiang, Z.Q., Spitalnik, S.L., Tran, M. et al. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132-140
11. 11 Xu, D. and Liew, F.Y. Genetic vaccination against leishmaniasis. Vaccine 1994, 12, 1534-1536
12. 12 Sedegah, M., Hedstrom, R.C., Hobart, P. and Hoffman, S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 1994, 91, 9866-9870
13. 13 Cox, G.J.M., Zamb, T.J. and Babiuk, L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 1993, 67, 5664-5667
14. + T lymphocytes. J. Immun. 1995, 155, 259-265
15. 15 Long, D., Madara, T.J., Ponce de Leone, M., Cohen, G.H., Montgomery, P.C. and Eisenberg, R.J. Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect. Immun. 1984, 37, 761-764
16. 16 Lasky, L.A., Dowbenko, D., Simonsen, C.C. and Berman, P.W. Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D. Biotechnology 1984, 2, 527-532
17. 17 Stanberry, L.R., Bernstein, D.I., Burke, R.L., Pachl, C. and Myers, M.G. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J. Infect. Dis. 1987, 155, 914-920
18. 18 Berman, P.W., Vogt, P.E., Gregory, T., Lasky, L.A. and Kern, E.R. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent and latent genital infections with herpes simplex virus type 2 in guinea pigs. J. Infect. Dis. 1988, 157, 897-902
19. 19 Schleiss, M.R., Degnin, C.R. and Geballe, A.P. Translational control of human cytomegalovirus gp48 expression. J. Virol. 1991, 65, 6782-6789
20. 20 Milligan, G.N. and Bernstein, D.I. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 1995, 206, 234-241
21. 21 Bernstein, D.I., Harrison, C.J., Jenski, L.J., Myers, M.G. and Stanberry, L.R. Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy. J. Immun. 1991, 146, 3571-3577
22. 22 Brandtzaeg, P. Overview of the mucosal immune system. Curr. Top. Microbiol. Immun. 1989, 146, 13-25
23. 23 Mestecky, J. The common mucosal immune system and current strategies for induction of immune response in external secretions. J. Clin. Immun. 1987, 7, 265-276
24. 24 Grammar, S.F., Sette, A., Colon, S., Walker, L. and Chesnut, R. Identification of an HSV-1/HSV-2 cross-reactive T cell determinant. J. Immun. 1990, 145, 2249-2253
25. 25 Ishizaka, S.T. and Mishkin, E.M. Native HSV glycoprotein D subunit vaccine: analysis of in vitro T-cell activation and antigen presentation. Viral Immun. 1991, 4, 187-193
26. 26 Martins, L.P., Lau, L.L., Asano, M.S. and Ahmed, R. DNA vaccination against persistent viral infection. J. Virol. 1995, 69, 2574-2582
27. 27 Yokoyama, M., Zhang, J. and Whitton, J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 1995, 69, 2684-2688
28. 28 Overall J.C. Jr, Kern, E.R., Schlitzer, R.L., Friedman, S.B. and Glasgow, L.A. Genital herpes hominis infection in mice. I. Development of an experimental model. Infect. Immun. 1975, 476-480
29. 29 Stanberry, L.R. Pathogenesis of herpes simplex virus infection and animal models for its study. Curr. Top. Microbiol. Immun. 1992, 179, 15-30
30. 30 McDermott, M.R., Smiley, J.R., Leslie, P., Brais, J., Rudzroga, H.E. and Bienenstock, J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 1984, 51, 747-753
31. 31 Kern, E.R. Acyclovir treatment of experimental genital herpes simplex virus infections. Am. J. Med. 1982, 73, 100-107
32. 32 Bravo, F.J., Stanberry, L.R., Kier, A.B., Vogt, P.E. and Kern, E.R. Evaluation of HPMPC therapy for primary and recurrent genital herpes im mice and guinea pigs. Antiviral Res. 1993, 21, 59-72
33. 33 Kapoor, A.K., Nash, A.A., Wildy, P., Phelan, J., McClean C.S. and Field, H.J. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 1982, 60, 225-233
34. 34 Kapoor, A.K., Nash, A.A. and Wildy, P. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell mediated and humoral immunity. J. Gen. Virol. 1982, 61, 127-131
35. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 1987, 68, 825-833